Panitumumab is a recombinant humanized monoclonal antibody used in the treatment of EGFR-expressing metastatic colorectal carcinoma that is refractory to chemotherapy regimens containing fluoropyrimidine, oxaliplatin, and irinotecan. The DrugMonitor™ Anti-Panitumumab Antibody (VS-1224-YC884) is an anti-drug antibody (ADA) against Panitumumab. This drug-based antibody is raised in mice immunized with the Panitumumab. The anti-Panitumumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Panitumumab in samples.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Anti-Human EGFR Recombinant Antibody (Panitumumab)Recombinant monoclonal antibody to Human EGFR. Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and HER1 in humans).
Afuco™ Anti-EGFR ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-020)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to Human EGFR. It is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and HER1 in humans).
There are currently no Customer reviews or questions for VS-1224-YC884. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.